Loopbaan van Jeffrey Molldrem
Eerdere bekende functies van Jeffrey Molldrem
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
The Vaccine Co.
 The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | 01-01-2003 | - |
| Oprichter | 01-11-2009 | - | |
| Corporate Officer/Principal | 01-07-2003 | 01-11-2009 |
Opleiding van Jeffrey Molldrem
| University of Minnesota | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Director/Board Member | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
The Vaccine Co.
The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Jeffrey Molldrem
- Ervaring
